1Study on the mechanism of apatinib mesylate inhibiting breast cancer cell proliferation through Erk1/2 signaling pathwayLIU Xinlan, HOU Yujin, LV Yan, GUO TingARTICLES481-4872Experimental study on shikonin induced programmed cell necrosis of non-small cell lung cancerHUANG Jingshan, ZHANG Hongyan, LU JibinARTICLES488-4923LncRNA HOTTIP promotes proliferation and metastasis of lung cancer cell via regulating miR-615/IGF2 axisGAO Xuefeng, YU Xuhui, ZHANG Rui, YU LiARTICLES493-4984Experimental study on reversal of acquired drug resistance of cervical cancer cells by GADD45A targeting inhibition of p38 MAPK pathwayWANG Xiaoping, LIU Haixia, ZHENG XiaoxiaARTICLES499-5055Experimental study of triptolide regulating PI3K/ Akt signaling pathway to inhibit proliferation and induce apoptosis of colon cancerZHANG Meirong, ZHANG Jing, ZHANG Yonggang, SONG Xiaoxia, ZHANG JingjingARTICLES506-5116Experimentalstudy on the effect of morusin on the proliferation of glioma U251 cells by regulating Wnt/β-catenin signaling pathwayNIU Jiangtao, YANG BoARTICLES512-5177Mechanism of microRNA-370 ontemozolomide sensitivityvia regulating MGMT expressionin glioma cellsTIAN Fengfu, ZHANG Xuefeng, ZHANG Wenjie, SHI JingguoARTICLES518-5228Expression of SUMO1P3 in serum exosomes and tissues of triple negative breast cancer and its clinical significanceZHANG Ke, ZHANG Kaijiong, WU Lichun, WANG Zuo, WU YouARTICLES523-5299Relationship between expression of CPT1A expression and therapeutic effect in bone marrow mononuclear cells of acute myeloidleukemiaLI Chuancui, WU Xifeng, SUN Ling, LI DandanARTICLES530-53610Level of circRNA circ_0080220 in non-small cell lung cancer tissues and its clinical significanceLI Liang, CAI Renzhong, LI Gao, HUANG XiumingARTICLES537-54011Clinical characteristics and classification of immunocheckpoint inhibitor-associated pneumonitisWANG Feng, QIN Shukui, HUA Haiqing, LIU Xiufeng, ZHAO Ying, SHI Yi, WANG Qin, CHENG Yuan, CAO Mengran, CHENG Yin, LI Hui, CHEN Xinni, XUN Chen, HAO LipingARTICLES541-54912Efficacy of sorafenib in the treatment of recurrent hepatocellular carcinoma after liver transplantationCHENG Ying, WANG Xuan, HUA Haiqing, ZHANG Donghua, ZHANG Rongsheng, JIANG Tao, LU LeiARTICLES550-55313Expression and clinical significance of miR-9 and MMP-14 in non-small cell lung cancerTURXUNJIANG Aili, CAO Guolei, CHEN Huifang, TANG Le, MA Ronghui, TONG Yushan, LUO QinCLINICAL PRACTICE554-55814Progression of PARP inhibitors in the comprehensive treatment of pancreatic cancerWU ChenchenREVIEWS AND LECTURES559-56315Advances of cell immunotherapy in human cancersZHANG Baihong, YUE HongyunREVIEWS AND LECTURES564-56816Characteristics and therapeutic progress of rare targets in advanced gastric cancerDU Caifang, LI HuiREVIEWS AND LECTURES569-574 